1. nFOPT®
2. AI+nFOPT®

1. RhythmSafe: Long-term home heart rhythm monitoring service. Paroxysmal arrhythmia can be tracked and its root causes identified through 14 days of continuous measurement. Post-operative monitoring for cardiac patients can detect abnormalities early, thereby enhancing post-surgery safety. High-risk groups can identify asymptomatic arrhythmia through regular check-ups to prevent strokes.

2. RhythmBalance: Mind-body balance assessment service. Long-term accumulation of internal and external factors such as poor sleep, high stress, and fatigue can lead to physiological system imbalances, which are often the underlying causes of prolonged illnesses. This service provides multiple indicators, including regulatory capacity, resilience, stress index, physiological age, and rapid heart rhythm screening, serving as a reference for clinical diagnosis.

3. HeartBeat 30: Atrial fibrillation (AFib) rapid screening service. It provides rapid ECG measurements for corporate employees, community elderly, and various volunteer groups, helping to identify potential AFib patients and effectively prevent strokes. Since 2018, the service has exceeded 20,000 sessions.

4. COVID-19 Home Care: Remote monitoring service for isolated patients. It tracks conditions such as myocardial inflammation caused by viral infections, or rapid and irregular heartbeats resulting from the side effects of therapeutic drugs. It is suitable for both in-hospital and home-isolated patients. This service platform has received US FDA Emergency Use Authorization (EUA #200441), making it the world's first remote physiological monitoring service for isolated COVID-19 patients assisted by AI technology. It can also be applied to the remote physiological monitoring of patients with various other diseases.

"AI-Screening" is an AI-powered biomedical interpretation system developed by Precision Biotech. It accelerates the identification of cardiovascular disease biomarkers, assists doctors and patients in obtaining comprehensive systemic cardiovascular hotspot analysis reports, and provides big data-driven analytical recommendation reports. The AI system can also analyze the relationship between daily diet and cardiovascular indices. This product has won the CES Taiwan Best Product Award and has completed clinical validation across medical institutions.

"BD-CARdio" is an ECG-AI interpretation system developed by Precision Biotech. It accelerates the generation of auxiliary analysis reports for cardiovascular diseases, assists doctors and patients in obtaining analysis reports for conditions such as arrhythmia, and provides big data-driven analytical recommendation reports. This product has completed clinical validation across four medical institutions and has successively won the Innovation Research Award from the Ministry of Economic Affairs and the Taipei Biotech Award.

Next-Generation Sleep Testing, ECG Monitor, Sleep Monitoring System